![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medecision (MM) | NASDAQ:MEDE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.00 | 0 | 01:00:00 |
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Expires: February 28, 2011 Estimated average burden hours per response... 0.5 |
|
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person
*
GREAT POINT PARTNERS LLC |
2. Issuer Name
and
Ticker or Trading Symbol
MEDecision, Inc. [ MEDE ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __ X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
, 165 MASON STREET, 3RD FLOOR |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
GREENWICH, CT 06830 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 7/1/2008 | P (1) | 161755 | A | $6.65 | 1132297 | I | By Biomedical Value Fund, L.P. (2) | ||
Common Stock | 7/7/2008 | S | 15871 | D | $6.6115 | 1116426 | I | By Biomedical Value Fund, L.P. (2) | ||
Common Stock | 7/8/2008 | S | 11129 | D | $6.5829 | 1105297 | I | By Biomedical Value Fund, L.P. (2) | ||
Common Stock | 7/8/2008 | S | 77223 | D | $6.5829 | 1028074 | I | By Biomedical Value Fund, L.P. (2) | ||
Common Stock | 7/8/2008 | S | 31500 | D | $6.5670 | 996574 | I | By Biomedical Value Fund, L.P. (2) | ||
Common Stock | 7/1/2008 | S (1) | 161755 | D | $6.65 | 665000 | I | By Biomedical Offshore Value Fund, Ltd. (3) | ||
Common Stock | 7/7/2008 | S | 9321 | D | $6.6115 | 655679 | I | By Biomedical Offshore Value Fund, Ltd. (3) | ||
Common Stock | 7/8/2008 | S | 51888 | D | $6.5829 | 603791 | I | By Biomedical Offshore Value Fund, Ltd. (3) | ||
Common Stock | 7/8/2008 | S | 9336 | D | $6.5700 | 594455 | I | By Biomedical Offshore Value Fund, Ltd. (3) | ||
Common Stock | 7/8/2008 | S | 9164 | D | $6.5700 | 585291 | I | By Biomedical Offshore Value Fund, Ltd. (3) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: | |
( 1) | On July 1, 2008, Biomedical Offshore Value Fund, Ltd. ("BOVF") sold 161,755 shares of Common Stock of MEDecision, Inc. to Biomedical Value Fund, L.P. ("BMVF") at a purchase price of $6.65 per share. The purchase price was the closing market price for the shares on June 30, 2008. |
( 2) | Great Point Partners, LLC ("Great Point") is the investment manager of BMVF and by virtue of such status may be deemed to be the beneficial owner of the shares held by BMVF. Each of Dr. Jeffrey R. Jay, M.D. ("Dr. Jay"), as senior managing member of Great Point, and Mr. David Kroin ("Mr. Kroin"), as special managing member of Great Point, has voting and investment power with respect to the shares held by BMVF and may be deemed to be the beneficial owner of the shares held by BMVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares held by BMVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities. |
( 3) | Great Point is the investment manager of BOVF and by virtue of such status may be deemed to be the beneficial owner of the shares held by BOVF. Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the shares held by BOVF and may be deemed to be the beneficial owner of the shares held by BOVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares held by BOVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
GREAT POINT PARTNERS LLC
165 MASON STREET, 3RD FLOOR GREENWICH, CT 06830 |
|
X |
|
|
|
JAY JEFFREY R
GREAT POINT PARTNERS, LLC 165 MASON STREET, 3RD FLOOR GREENWICH, CT 06830 |
|
X |
|
|
|
KROIN DAVID
C/O GREAT POINT PARTNERS LLC 165 MASON STREET, 3RD FLOOR GREENWICH, CT 06830 |
|
X |
|
|
Signatures
|
||
/s/ Dr. Jeffrey R. Jay, M.D., as senior managing member | 7/9/2008 | |
** Signature of Reporting Person |
Date
|
|
/s/ Dr. Jeffrey R. Jay, M.D. | 7/9/2008 | |
** Signature of Reporting Person |
Date
|
|
/s/ Mr. David Kroin | 7/9/2008 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Medecision (MM) Chart |
1 Month Medecision (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions